Genetic counseling and the ethical issues around direct to consumer genetic testing

Journal of Genetic Counseling

Volumn 21, Issue 3, 2012, Pages 367-373

  Hawkins, Alice K ^a   Ho, Anita ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Direct to consumer genetic testing; Ethics; Genetic counseling values

Indexed keywords

ARTICLE; CONSUMER; ETHICS; FREEDOM; GENETIC COUNSELING; GENETIC SCREENING; HUMAN;

CONSUMER PARTICIPATION; ETHICS; FREEDOM; GENETIC COUNSELING; GENETIC TESTING; HUMANS;

EID: 84863625960     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-012-9488-8     Document Type: Article

References (47)

1. ACMG (2004). ACMG statement on direct-to-consumer genetic testing. Genetics in Medicine, 6(1), 60.
2. Angrist, M. (2009). We are the genes we've been waiting for: rational responses to the gathering storm of personal genomics. The American Journal of Bioethics, 9(6), 30-31.
3. Armstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. (2005). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA: The Journal of the American Medical Association, 293(14), 1729-1736.
4. Beauchamp, T., & Childress, J. (2009). Principles of biomedical ethics. USA: Oxford University Press.
5. Bloss, C., Ornowski, L., Silver, E., Cargill, M., Vanier, V., Schork, N., et al. (2010). Consumer perceptions of direct to consumer personalized genomic risk assessments. Genetics in Medicine, 12(9), 556-566.
6. Bloss, C., Schork, N., & Topol, E. (2011). Effect of direct to consumer genomewide profiling to assess disease risk. The New England Journal of Medicine, 364(6), 524-534.
7. Bloss, C. S., Topol, E. J., & Schork, N. J. (2011). Association of directtoconsumer genome-wide disease risk estimates and self-reported disease. Genetic Epidemiology. doi:10.1002/gepi.20664.
8. Brice, P. (2010). Current DTC genetic testing market smaller than expected. http://www.phgfoundation.org/news/5658/. Accessed May 30 2011.
9. Burke, W., & Psaty, B. (2007). Personalized medicine in the era of genomics. JAMA: Journal of the American Medical Association, 298(14), 1682-1684. (Pubitemid 47606657)
10. Burke, S., Martyn, M., Stone, A., Bennett, C., Thomas, H., & Farndon, P. (2009). Developing a curriculum statement based on clinical practice: genetics in primary care. British Journal of General Practice, 59(559), 99-103.
11. Caulfield, T. (2009). Direct to consumer genetics and health policy: a worst-case scenario? The American Journal of Bioethics, 9(6 & 7), 48-50.
12. Daniels, N. (2001). Justice, health, and healthcare. American Journal of Bioethics, 1(2), 2-16.
13. Geransar, R., & Einsiedel, E. (2008). Evaluating online direct to consumer marketing of genetic tests: informed choices or buyers beware? Genetic testing, 12(1), 13-23. (Pubitemid 351457776)
14. Gillon, R. (1986). Philosophical Medical Ethics. Wiley and Son.
15. Giovanni, M. A., Fickie, M. R., Lehmann, L. S., Green, R. C., Meckley, L. M., Veenstra, D., et al. (2010). Health-care referrals from direct to consumer genetic testing. Genetic Testing and Molecular Biomarkers, 14(6), 817-819.
16. Gollust, S. E., Hull, S. C., & Wilfond, B. S. (2002). Limitations of direct to consumer advertising for clinical genetic testing. JAMA: Journal of the American Medical Association, 288(14), 1762-1767.
17. Green, R. C., Roberts, J. S., Cupples, L. A., Relkin, N. R., Whitehouse, P. J., Brown, T., et al. (2009). Disclosure of APOE genotype for risk of Alzheimer's disease. The New England Journal of Medicine, 361(3), 245-254.
18. Guttmacher, A. E., Porteous, M. E., & McInerney, J. D. (2007). Educating health-care professionals about genetics and genomics. Nature Reviews Genetics, 8(2), 151-157. (Pubitemid 46122843)
19. Hall, M., & Olopade, O. I. (2005). Confronting genetic testing disparities. JAMA: The Journal of the American Medical Association, 293(14), 1783-1785.
20. Headings, V. (1997). Revisiting foundations of autonomy and beneficence in genetic counseling. Genetic Counseling, 8(4), 291-294. (Pubitemid 28014810)
21. Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine, 10(1), 19-32.
22. Hock, K. T., Christensen, K. D., Yashar, B. M., Roberts, J. S., Gollust, S. E., & Uhlmann, W. R. (2011). Direct to consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs. Genetics in Medicine, 13(4), 325-332.
23. Howard, H., & Borry, P. (2009). Personal genome testing: do you know what you are buying? The American Journal of Bioethics, 9(6), 11-34.
24. Hsu, A., Mountain, J., Wojcicki, A., & Avey, L. (2009). A pragmatic consideration of ethical issues relating to personal genomics. The American Journal of Bioethics, 9(6), 1-2.
25. Hudson, K., Javitt, G., Burke, W., & Byers, P. (2007). ASHG statement on direct to consumer genetic testing in the United States. American Journal of Human Genetics, 81(3), 635-637.
26. Hunter, A. G. W., Sharpe, N., Mullen, M., & Meschino, W. S. (2001). Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics. American Journal of Medical Genetics, 103(4), 265-276. (Pubitemid 32988590)
27. Janssens, A. C., Gwinn, M., Bradley, L. A., Oostra, B. A., van Duijn, C. M., & Khoury, M. J. (2008). A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. American Journal Human Genetics, 82(3), 593-599. (Pubitemid 351726114)
28. Jonsen, A. R. (1986). Casuistry and clinical ethics. Theoretical Medicine and Bioethics, 7(1), 65-74.
29. Jordens, C., Kerridge, I., & Samuel, G. (2009). Direct to consumer personal genome testing: the problem is not ignorance - it is market failure. The American Journal of Bioethics, 9(6), 13-14.
30. Kaphingst, K. A., McBride, C. M., Wade, C., Alford, S. H., Brody, L. C., & Baxevanis, A. D. (2010). Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testing. Journal of Medical Internet Research, 12(3), e41.
31. Karns, L., Roche, M., & Yashar, B. (2005). An ethics casebook for genetic counselors, 2nd Edition: Ethical discourse for the practice of genetic counseling. New York: Springer.
32. Marchant, G., Milligan, R., & Wilhelmi, B. (2006). Legal pressures and incentives for personalized medicine. Personalized Medicine, 3(4), 391-397. (Pubitemid 46017511)
33. McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2009). Characteristics of users of online personalized genomic risk assessments: implications for physicianpatient interactions. Genetics in Medicine, 11(8), 582-587.
34. McGuire, A., & Burke, W. (2008). An unwelcome side effect of direct to consumer personal genome testing: raiding the medical commons. Journal of the American Medical Association, 300(22), 2669-2671.
35. McGuire, A., Diaz, C., Hilsenbeck, S., & Wang, T. (2009). Social networkers' attitudes toward direct to consumer personal genome testing. The American Journal of Bioethics, 9(6), 3-10.
36. Miller, R. (1996). Casuistry and modern ethics: A poetics of practical reasoning. Chicago: University of Chicago Press.
37. NSGC (2006). Code of Ethics. http://www.nsgc.org/Advocacy/ NSGCCodeofEthics/tabid/155/Default.aspx. Accessed May 20, 2011.
38. Offit, K. (2008). Genomic profiles for disease risk: predictive or premature? JAMA: Journal of the American Medical Association, 299(11), 1353-1355. (Pubitemid 351439082)
39. Offit, K., Groeger, E., Turner, S., Wadsworth, E. A., & Weiser, M. A. (2004). The" duty to warn" a patient's family members about hereditary disease risks. JAMA: The Journal of the American Medical Association, 292(12), 14691473.
40. Salkin, A. (2008). When in Doubt, Spit It Out. (Sep. 14th). New York Times.
41. Schmerler, S. (1999). Ethical and legal issues. In D. Baker, J. Schuette, & W. Uhlmann (Eds.), A guide to genetic counseling. New York: Wiley and Sons.
42. Sirovich, B., Woloshin, S., & Schwartz, L. (2011). Too little? Too much? Primary care physicians' views on us health care a brief report. Archives of Internal Medicine, 171(17), 1582-1585.
43. Wade, C. H., & Wilfond, B. S. (2006). Ethical and clinical practice considerations for genetic counselors related to direct to consumer marketing of genetic tests. Journal of Medical Genetics, 142(4), 284-292. (Pubitemid 44747456)
44. Wasson, K., Cook, E., & Helzlsouer, K. (2006). Direct to consumer online genetic testing and the four principles: an analysis of the ethical issues. Ethics and Medicine, 22(2), 83-91.
45. Weil, J. (2000). Psychosocial genetic counseling. USA: Oxford University Press.
46. Weil, J. (2003). Psychosocial genetic counseling in the post-nondirective era: a point of view. Journal of Genetic Counseling, 12(3), 199-211. (Pubitemid 39024189)
47. Williams, M. (2007). Insurance coverage for pharmacogenomic testing in the USA. Personalized Medicine, 4(4), 479-487. (Pubitemid 350303109)